Ryuzo Orihashi
Research Interests
Make your next move.
Prepare your application
Review drafts before you send them.
Explore related searches
Articles (15)
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2026
Year:
2025
Aim The aging of the global population has made healthy aging and the extension of healthy life expectancy significant challenges for many societies. Mental health, including cognitive function, is critical to the quality of life of older adults. Oxytocin, a neuropeptide involved in social bonding and stress regulation, has been shown to exert neuroprotective effects, while S100B, a calcium‐binding protein, has been linked to neuroinflammation and neurodegenerative disorders, such as Alzheimer's disease. However, the relationship between oxytocin and S100B levels during aging remains unclear. This study investigated the association between serum oxytocin and S100B levels in community‐dwelling older adults. Methods This survey, conducted between November 2016 and September 2017 in Kurokawa‐cho, Imari, Saga Prefecture, Japan, included community‐dwelling older adults aged ≥65 years. Blood samples were collected to measure serum oxytocin and S100B levels using an enzyme‐linked immunosorbent assay. The relationships among serum oxytocin, S100B, and cognitive function (Mini‐Mental State Examination, Frontal Assessment Battery, and Clinical Dementia Rating) were analyzed using correlation and multiple regression analyses. Results A total of 95 participants (25 men, 70 women; mean age: 78.03 ± 5.12 years) were analyzed. Our analysis showed that serum oxytocin levels were negatively associated with serum S100B levels even after adjusting for age, sex, years of education, and body mass index. However, no significant correlations were found between these biomarkers and overall cognitive function. Conclusion These findings suggest that the neuroprotective effects of oxytocin may influence blood S100B levels, though its direct role in cognitive function remains unclear.
Year:
2025
Year:
2024
Year:
2024
Background The noradrenergic systems in the brain maintain cognitive functions including attention/concentration and establishment of long‐term memory. In addition, hypofunction of noradrenergic systems is supposed to be involved in the pathophysiology of Alzheimer's disease. In this study, we tried to examine the possible associations of concentrations of basal salivary 3‐methoxy‐4‐hydroxyphenylglycol (sMHPG), a major metabolite of noradrenaline, and brain volume changes during 4 years in elderly people living in a rural community. Methods The survey was conducted twice in Kurokawa‐cho, Imari, Saga Prefecture, Japan, among people aged 65 years and older. We collected data from 226 residents. Measurements of sMHPG and brain MRIs were collected at Time 1 (2005–2007). Follow‐up brain MRIs were taken at Time 2 (2009–2011). A total of 70 participants (18 men, mean age 71.9 ± 4.8 years; 52 women, mean age 72.0 ± 4.3 years) completed this survey. Concentrations of sMHPG at baseline were divided into two groups using the mean value (12.83 ng/ml). We compared the brain volumes between groups with higher and lower sMHPG concentrations over time using voxel‐based morphometry implemented with statistical parametric mapping. Results In participants with higher sMHPG concentrations at baseline, brain volumes including right precuneus were significantly larger 4 years after baseline than those with lower sMHPG concentrations at baseline. No interaction between sMHPG concentration and MRI acquisition interval was found. Conclusion Our results suggest that higher sMHPG concentrations in elderly people might be associated with maintenance of brain volume, especially in brain regions closely related to cognitive function.
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2021
Year:
2020
Collaborators (1)
Yoshito Mizoguchi
-
Make your next move.
Prepare your application
Review drafts before you send them.